<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Ebola</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Ebola.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/diseases/ebola.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Field Investigation of the Bundibugyo Ebola Virus Disease (BDBV) Outbreak in Ituri Province, Democratic Republic of the Congo: Challenges, Strategies, and Priority Actions for Outbreak Control—An Outbreak Investigation Review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-idr18050100-0286cca8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-idr18050100-0286cca8/</guid>
    <pubDate>Tue, 08 Sep 2026 00:00:00 GMT</pubDate>
    <description>The abstract frames the outbreak as a major Ebola control challenge in a conflict-affected and socially complex setting. It identifies surveillance, contact tracing, laboratory capacity, IPC, clinical care, risk communication, misinformation management, and community trust as priority areas for outbreak response and preparedness.</description>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Outbreak investigation</category>
  </item>
  <item>
    <title>Implementing an intra outbreak ring vaccination clinical trial for Sudan Ebola virus disease within four days of outbreak notification in Uganda.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2026-2731496-7d1abb29/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2026-2731496-7d1abb29/</guid>
    <pubDate>Mon, 07 Sep 2026 00:00:00 GMT</pubDate>
    <description>The four-day turnaround provides a replicable blueprint for rapid medical countermeasure evaluation during future outbreaks in settings with heightened Ebola Virus Disease threat. The approach demonstrates that prepositioned protocols, established infrastructure, and trained personnel can dramatically compress trial activation timelines.</description>
    <category>Ebola</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Regional signals preceding the 2026 Bundibugyo virus disease outbreak</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108862-d477aad3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108862-d477aad3/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>Findings point to potential deficiencies in protocols for managing cases that test negative for standard pathogens.</description>
    <category>Hemorrhagic Fever</category>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Diagnostics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>The 2026 Bundibugyo virus disease outbreak in the Democratic Republic of the Congo: Virology, epidemiology, continental response, and research priorities</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-imj-2026-100270-6c5ddd42/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-imj-2026-100270-6c5ddd42/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>The document underscores urgent requirements for novel prophylactic and therapeutic development while demonstrating how transnational coordination mechanisms can address complex outbreak environments marked by infrastructure deficits and social friction.</description>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Challenges in managing ruptured ectopic pregnancy complicated by hemorrhagic shock in an Ebola treatment unit in DR Congo: first reported case</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fmed-2026-1848720-5309eb14/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fmed-2026-1848720-5309eb14/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>The case indicates that obstetric emergencies can arise in Ebola treatment units and that limited diagnostic, surgical, anesthetic, and referral capacity may complicate timely care. The authors conclude that such units should have capacity to diagnose and manage obstetric complications in addition to providing Ebola-related care.</description>
    <category>Ebola</category>
    <category>Malaria</category>
    <category>Treatment</category>
    <category>Diagnostics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Ebola Virus Disease: Hematologic Insights and Public Health Innovations- A Narrative Review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-67224-ioasdjmps-2026-v03i03-011-c3cb5e83/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-67224-ioasdjmps-2026-v03i03-011-c3cb5e83/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>The review highlights multidisciplinary integration of hematologic insights with diagnostics, therapeutics, vaccination, and surveillance to reduce mortality and improve outbreak response.</description>
    <category>Ebola</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Vaccination</category>
    <category>Diagnostics</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Dynamic modeling and optimal control of Mpox among MSM in a central Chinese city</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12889-026-28925-6-0a0b55e9/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12889-026-28925-6-0a0b55e9/</guid>
    <pubDate>Sat, 15 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings offer a quantitative basis for prioritizing resource distribution during localized mpox surges. They illustrate how adaptive management of prevention, screening, clinical access, and immunization can improve outbreak containment outcomes.</description>
    <category>Monkeypox</category>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Pan-Ebolavirus nanoparticle vaccine provides protection in rodents from lethal infection by Zaire and Sudan viruses</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-76114-1-dbca88c1/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-76114-1-dbca88c1/</guid>
    <pubDate>Sat, 08 Aug 2026 00:00:00 GMT</pubDate>
    <description>Findings support continued development of a pan-ebolavirus vaccine built on the I53-50 platform, which has established clinical safety, and may be relevant for populations at risk of EBOV and SUDV outbreaks.</description>
    <category>Hemorrhagic Fever</category>
    <category>Ebola</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Water, Sanitation and Hygiene in Ebola Preparedness and Response in South Sudan, Uganda and the Democratic Republic of the Congo: A Scoping Review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-19044-esipreprint-8-2026-p97-24674607/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-19044-esipreprint-8-2026-p97-24674607/</guid>
    <pubDate>Sat, 08 Aug 2026 00:00:00 GMT</pubDate>
    <description>Embedding durable environmental services, practical staff education, community outreach, and regional cooperation into standard health budgets could improve future epidemic resilience.</description>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Operationalizing One Digital Health and FAIR Data Principles for Disease Surveillance in a Low-Medium Income Country in Africa: Qualitative Study in the Democratic Republic of the Congo.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2196-93321-deacb4af/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2196-93321-deacb4af/</guid>
    <pubDate>Wed, 05 Aug 2026 00:00:00 GMT</pubDate>
    <description>The analysis supplies practical guidance for resource-constrained regions aiming to replace disconnected digital projects with coordinated, compatible networks that support comprehensive pathogen tracking.</description>
    <category>COVID-19</category>
    <category>Ebola</category>
    <category>Monkeypox</category>
    <category>Surveillance</category>
    <category>One Health</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Ethical challenges in outbreak trial design: from Ebola to Nipah</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128858-16db05e0/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128858-16db05e0/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The discussion is relevant to accelerating ethically acceptable evaluation of Nipah and other outbreak vaccines, including the role of early and sustained community engagement across epidemic and inter-epidemic periods.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Exploring the Potential Contribution of Climate-Informed Research to Future Ebola Preparedness in Central Africa.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-v18070782-3f9e0b9a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-v18070782-3f9e0b9a/</guid>
    <pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate>
    <description>Frequent viral outbreaks in the specified region underscore the necessity of transitioning from reactive case management to proactive risk evaluation. Integrating ecological tracking with conventional diagnostic networks may ultimately refine strategic planning for regional health authorities.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Climate and environment</category>
    <category>Outbreak investigation</category>
    <category>One Health</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>Donor dependency and pandemic readiness: insights from the 2026 Ebola Bundibugyo outbreak in the East African community.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fpubh-2026-1891266-a2986612/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fpubh-2026-1891266-a2986612/</guid>
    <pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate>
    <description>Strengthening localized financing and institutionalizing border-spanning monitoring networks could reduce systemic fragility during future pathogen emergencies.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>Bundibugyo Virus Disease Outbreak and Cross-Border Response in the Democratic Republic of the Congo and Uganda, May-June 2026.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-7759-cureus-112459-e636cd4f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-7759-cureus-112459-e636cd4f/</guid>
    <pubDate>Sat, 11 Jul 2026 00:00:00 GMT</pubDate>
    <description>The discussion underscores the importance of adaptable international cooperation and localized preparedness when addressing novel hemorrhagic fever threats lacking established medical interventions.</description>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Travel medicine</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>Ebola outbreak in the Democratic Republic of the Congo: Lessons from Kasai (2025) and emerging challenges from the Bundibugyo resurgence</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-36922-mi025010145-cc4b9789/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-36922-mi025010145-cc4b9789/</guid>
    <pubDate>Fri, 10 Jul 2026 00:00:00 GMT</pubDate>
    <description>By contrasting successful containment tactics with unresolved logistical barriers, the text underscores the importance of adaptable monitoring networks and region-specific medical countermeasures for managing recurring viral threats.</description>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Vaccination</category>
    <category>Transmission dynamics</category>
    <category>Surveillance</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>Identification of Contacts With High Rates of Missed and Asymptomatic Infection Following an Outbreak of Ebola Virus Disease: A Seroepidemiological Study in Likati Health Zone, Democratic Republic of the Congo.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-ofid-ofag397-1107525d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-ofid-ofag397-1107525d/</guid>
    <pubDate>Tue, 07 Jul 2026 00:00:00 GMT</pubDate>
    <description>Undetected infections among both monitored and unmonitored contacts indicate that standard tracking protocols likely miss a significant portion of viral spread. Routine blood screening following outbreaks could clarify transmission networks and improve future response planning.</description>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Bundibugyo virus detection during an Ebola virus disease outbreak in the democratic Republic of the Congo: an urgent call for action.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s41182-026-01015-4-1e848a43/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s41182-026-01015-4-1e848a43/</guid>
    <pubDate>Mon, 06 Jul 2026 00:00:00 GMT</pubDate>
    <description>Identifying this viral variant demonstrates the requirement for expanded regional monitoring networks and upgraded laboratory infrastructure. Enhancing these operational capacities remains essential for effective emergency management.</description>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>Outbreak investigation</category>
  </item>
  <item>
    <title>Editorial: The WHO Identifies Ebola Disease Due to Bundibugyo Virus as a Public Health Emergency of International Concern (PHEIC) as Vaccine Development Accelerates.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-12659-msm-954627-55727a36/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-12659-msm-954627-55727a36/</guid>
    <pubDate>Wed, 01 Jul 2026 00:00:00 GMT</pubDate>
    <description>The discussion emphasizes the operational necessity of deploying medical countermeasures during declared crises, especially when conventional clinical management proves insufficient for lowering death rates.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>It&apos;s not just virology: The Bundibugyo Ebola outbreak in the Democratic Republic of the Congo and Uganda demands a wider public health response.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-29063-ajrh2026-v30i13-1-3cdaa5c3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-29063-ajrh2026-v30i13-1-3cdaa5c3/</guid>
    <pubDate>Wed, 01 Jul 2026 00:00:00 GMT</pubDate>
    <description>The manuscript calls for integrating socioeconomic and environmental interventions into standard outbreak management frameworks to improve long-term resilience.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Closing Critical Gaps in the 2026 Bundibugyo Ebola Response: Five Actionable Priorities.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-7759-cureus-111921-46b92e7b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-7759-cureus-111921-46b92e7b/</guid>
    <pubDate>Wed, 01 Jul 2026 00:00:00 GMT</pubDate>
    <description>Outlining rapid, scalable measures deployable through current infrastructure, the discussion highlights how targeted operational shifts may improve immediate outbreak management while strengthening long-term regional readiness.</description>
    <category>Ebola</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Genomic epidemiology</category>
    <category>Diagnostics</category>
    <category>One Health</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>Healthcare-associated transmission and early IPC system vulnerabilities during the 2026 Bundibugyo Ebola outbreak in eastern Democratic Republic of the Congo</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s13756-026-01779-8-c7594305/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s13756-026-01779-8-c7594305/</guid>
    <pubDate>Wed, 24 Jun 2026 00:00:00 GMT</pubDate>
    <description>The authors suggest that immediate deployment of broad infection control protocols upon symptom onset could mitigate risks associated with diagnostic delays in resource-constrained environments.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Diagnostics</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>Strategic Preparedness for the FIFA World Cup 2026 in Response to the Bundibugoy Ebola Outbreak in the Democratic Republic of Congo</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-jtm-taag056-21e54eb9/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-jtm-taag056-21e54eb9/</guid>
    <pubDate>Mon, 22 Jun 2026 00:00:00 GMT</pubDate>
    <description>The discussion identifies operational gaps in managing transmissible disease threats during high-density international tourism and sports tournaments.</description>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Travel medicine</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Assessment of Risk to the U.S. Population from the Ebola Disease Outbreak Caused by Bundibugyo Virus, 2026.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7522e2-ab9bf047/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7522e2-ab9bf047/</guid>
    <pubDate>Thu, 11 Jun 2026 00:00:00 GMT</pubDate>
    <description>The evaluation outlines domestic preparedness thresholds and clarifies resource requirements for managing imported viral hemorrhagic fever scenarios.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Willingness to receive Ebola vaccines among pregnant and lactating women in Kampala, Uganda: insights from a post-outbreak cross-sectional study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128737-43c54279/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128737-43c54279/</guid>
    <pubDate>Mon, 01 Jun 2026 00:00:00 GMT</pubDate>
    <description>Results underscore the necessity of incorporating maternal populations into emergency immunization protocols while simultaneously deploying targeted educational initiatives to mitigate safety concerns and knowledge deficits.</description>
    <category>Ebola</category>
    <category>COVID-19</category>
    <category>Hemorrhagic Fever</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>The risk of global Ebola virus spread is low: epidemiology of Ebola disease cases outside Africa, 1976 to May 2026.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2026-31-24-2600508-47cbdcf8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2026-31-24-2600508-47cbdcf8/</guid>
    <pubDate>Mon, 01 Jun 2026 00:00:00 GMT</pubDate>
    <description>These findings contextualize cross-border transmission probabilities and may assist in evaluating international health security measures and travel-related screening protocols.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Travel medicine</category>
    <category>Transmission dynamics</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>WHO emergency guidance on the use of licensed Ebola virus vaccine during Bundibugyo virus disease outbreaks, 28 May 2026</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2471-b09772-e19a270b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2471-b09772-e19a270b/</guid>
    <pubDate>Thu, 28 May 2026 00:00:00 GMT</pubDate>
    <description>The guidance addresses vaccine deployment decisions during a declared international health emergency and reinforces reliance on core public health measures while calling for accelerated development and evaluation of Bundibugyo-specific and broadly protective filovirus vaccines.</description>
    <category>Ebola</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Congo’s conflicts, minerals and microbes: planetary health implications</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1136-bmjgh-2025-022261-eb59d98a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1136-bmjgh-2025-022261-eb59d98a/</guid>
    <pubDate>Thu, 07 May 2026 00:00:00 GMT</pubDate>
    <description>The commentary highlights that without parallel investments in disease surveillance and preparedness systems, expanding mineral extraction could accelerate both regional instability and global health threats through potential transboundary pathogen spread, necessitating integrated One Health approaches.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Climate and environment</category>
    <category>One Health</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>‘Our problem here is the pig Ebola’: local accounts of epizootics preceding Ebola outbreaks in north-eastern Democratic Republic of the Congo</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1136-medhum-2025-013586-27ce4306/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1136-medhum-2025-013586-27ce4306/</guid>
    <pubDate>Wed, 01 Apr 2026 00:00:00 GMT</pubDate>
    <description>Documenting regional narratives surrounding animal illness provides valuable context for understanding how communities interpret and report emerging health threats.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Investigating the Sudan virus outbreak in Uganda through the deployment of a mobile laboratory</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-12556-8-67e9ba93/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-12556-8-67e9ba93/</guid>
    <pubDate>Fri, 16 Jan 2026 00:00:00 GMT</pubDate>
    <description>Co-locating a mobile laboratory with the treatment unit shortened diagnostic turnaround, supported national data-driven decision-making, and enabled follow-up surveillance relevant to outbreak containment and survivor counselling.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Rift Valley fever</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Negligence and global health: the case of the 2018 ebola outbreak in the Democratic Republic of the Congo</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1590-interface-260322-32efaa44/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1590-interface-260322-32efaa44/</guid>
    <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
    <description>Understanding the political mechanisms that influence emergency classification helps explain disparities in international aid distribution and response scaling during cross-border epidemics.</description>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>Assessment of Epidemic Preparedness for Ebola Virus Disease and Hantavirus in the Kokolo Military Health Zone, Democratic Republic of the Congo</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-56147-jidpc-3-1-36-a48f1da8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-56147-jidpc-3-1-36-a48f1da8/</guid>
    <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
    <description>The report underscores the necessity for sustained resource allocation, supply chain optimization, and interagency cooperation to preserve outbreak resilience within defense healthcare networks confronting recurring and novel viral hazards.</description>
    <category>Ebola</category>
    <category>Monkeypox</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Outbreak of Marburg Virus Disease, Equatorial Guinea, 2023</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid3105-241749-72436339/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid3105-241749-72436339/</guid>
    <pubDate>Thu, 01 May 2025 00:00:00 GMT</pubDate>
    <description>The abstract emphasizes early isolation of symptomatic patients, community engagement, and stronger surveillance as priorities for outbreak control. It also notes that additional outbreak analysis and a One Health surveillance approach may support preparedness for possible future spillover events.</description>
    <category>COVID-19</category>
    <category>Marburg virus disease</category>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Development of a non-infectious control for viral hemorrhagic fever PCR assays</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0011390-dbb43ad8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0011390-dbb43ad8/</guid>
    <pubDate>Mon, 22 Apr 2024 00:00:00 GMT</pubDate>
    <description>The paper addresses a practical need for safer positive controls in disease surveillance testing when authentic positive material is limited or poses handling risks. It is relevant to diagnostics and assay validation workflows.</description>
    <category>Lassa</category>
    <category>Hemorrhagic Fever</category>
    <category>Rift Valley fever</category>
    <category>Ebola</category>
    <category>Marburg virus disease</category>
    <category>Crimean-Congo hemorrhagic fever</category>
    <category>One Health</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Sudan virus disease outbreak in Uganda: urgent research gaps</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1136-bmjgh-2022-010982-b4e8d0a7/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1136-bmjgh-2022-010982-b4e8d0a7/</guid>
    <pubDate>Fri, 30 Dec 2022 00:00:00 GMT</pubDate>
    <description>The authors highlight limited SUDV research investment, no licensed vaccine or therapeutics, ongoing transmission across regions of Uganda including the capital, and an uncertain case count as drivers of concern.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>COVID-19</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Mapping of Ebola virus spillover: Suitability and seasonal variability at the landscape scale</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0009683-9f4cd271/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0009683-9f4cd271/</guid>
    <pubDate>Mon, 23 Aug 2021 00:00:00 GMT</pubDate>
    <description>The authors frame GIS-MCE suitability maps as an updatable tool to support surveillance and prevention of future Ebola outbreaks as new knowledge becomes available.</description>
    <category>Ebola</category>
    <category>One Health</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Ebola Virus Infection Associated with Transmission from Survivors</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid2502-181011-73945b93/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid2502-181011-73945b93/</guid>
    <pubDate>Fri, 01 Feb 2019 00:00:00 GMT</pubDate>
    <description>The findings underscore the continued importance of Ebola survivor services, sustained surveillance, and response capacity in regions previously affected by widespread transmission.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>COVID-19</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Ebola virus disease: an update on post-exposure prophylaxis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-17-30677-1-96bf2610/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-17-30677-1-96bf2610/</guid>
    <pubDate>Fri, 01 Jun 2018 00:00:00 GMT</pubDate>
    <description>Post-exposure prophylaxis may contribute to outbreak control by protecting exposed health-care workers and reducing onward transmission in communities during future Ebola virus disease outbreaks.</description>
    <category>Ebola</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-17-30313-4-26a9403a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-17-30313-4-26a9403a/</guid>
    <pubDate>Tue, 01 Aug 2017 00:00:00 GMT</pubDate>
    <description>Findings informed dose selection for subsequent phase 3 evaluation of the rVSV∆G-ZEBOV-GP candidate, contributing evidence toward a deployable Ebola virus vaccine following the 2014 Zaire Ebola virus outbreak.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>Late Ebola virus relapse causing meningoencephalitis: a case report</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-16-30386-5-2a446f07/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-16-30386-5-2a446f07/</guid>
    <pubDate>Fri, 01 Jul 2016 00:00:00 GMT</pubDate>
    <description>This report documents the first described case of late, severe Ebola relapse in the central nervous system, suggesting the need for ongoing vigilance among thousands of Ebola survivors for relapsed infection, with consideration of transmission potential.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1056-nejmoa1411627-29a1f0cd/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1056-nejmoa1411627-29a1f0cd/</guid>
    <pubDate>Thu, 28 Apr 2016 00:00:00 GMT</pubDate>
    <description>Development of an effective Ebola vaccine was identified as a priority for controlling future outbreaks following the West African epidemic that caused over 11,000 deaths.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-15-00486-7-1b1ae76c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-15-00486-7-1b1ae76c/</guid>
    <pubDate>Tue, 01 Mar 2016 00:00:00 GMT</pubDate>
    <description>The paper is relevant to Ebola vaccine development because it provides early human safety and immune-response data for a candidate vaccine during an outbreak context. It is positioned as evidence to support later-phase efficacy studies rather than as a population-level effectiveness assessment.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2016-01-016-b046cacb/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2016-01-016-b046cacb/</guid>
    <pubDate>Mon, 01 Feb 2016 00:00:00 GMT</pubDate>
    <description>Polyclonal antibody production is presented as a potential platform to address longstanding neglected tropical diseases and emerging infectious threats where prophylactic and therapeutic options remain limited.</description>
    <category>Influenza</category>
    <category>MERS</category>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Rabies</category>
    <category>Dengue</category>
    <category>Diphtheria</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Treatment</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>The use of pseudotypes to study viruses, virus sero-epidemiology and vaccination</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2015-04-071-b785c3bb/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2015-04-071-b785c3bb/</guid>
    <pubDate>Mon, 01 Jun 2015 00:00:00 GMT</pubDate>
    <description>The article identifies pseudotype technology as relevant to research on pathogens described as important to human and animal health, particularly where access to high-containment facilities is limited. The abstract supports a research and laboratory-capacity relevance, but does not provide evidence of population-level health effects.</description>
    <category>Ebola</category>
    <category>Rabies</category>
    <category>Hemorrhagic Fever</category>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>One Health</category>
    <category>Treatment</category>
    <category>Travel medicine</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-15-60553-0-d75ff618/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-15-60553-0-d75ff618/</guid>
    <pubDate>Mon, 01 Jun 2015 00:00:00 GMT</pubDate>
    <description>This is an early clinical evaluation of an Ebola vaccine candidate, so it is relevant to vaccine development and preparedness work. The study addresses a vaccine targeting the 2014 epidemic strain rather than providing outbreak surveillance evidence.</description>
    <category>Ebola</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Treatment</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-14-62385-0-38ad575b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-14-62385-0-38ad575b/</guid>
    <pubDate>Wed, 01 Apr 2015 00:00:00 GMT</pubDate>
    <description>The paper is relevant to vaccine development for two high-fatality viral diseases and to early clinical evaluation of candidate vaccines in an African setting. It also provides context for later development work on Ebola vaccine antigens.</description>
    <category>Ebola</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1056-nejmoa1411100-bc1ed17c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1056-nejmoa1411100-bc1ed17c/</guid>
    <pubDate>Thu, 16 Oct 2014 00:00:00 GMT</pubDate>
    <description>A central West Africa Ebola epidemic analysis connecting case surveillance with forward projections.</description>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Surveillance</category>
    <category>Mathematical modelling</category>
  </item>
  <item>
    <title>A New Approach for Monitoring Ebolavirus in Wild Great Apes</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0003143-18670564/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0003143-18670564/</guid>
    <pubDate>Thu, 18 Sep 2014 00:00:00 GMT</pubDate>
    <description>The abstract describes possible public health relevance because identifying outbreaks in great apes may help characterize situations involving contact with infected wildlife carcasses. It also states that such detection could affect local communities where Ebola virus disease has high reported case-fatality rates, but the supplied evidence does not measure a public health effect.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-nature10380-02e920ff/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-nature10380-02e920ff/</guid>
    <pubDate>Wed, 24 Aug 2011 00:00:00 GMT</pubDate>
    <description>The abstract presents Ebola virus as a high-concern pathogen because outbreaks can involve severe disease, substantial mortality, transmission concerns, and limited preventive or therapeutic options. The findings are relevant to antiviral target discovery, based on the authors&apos; conclusion that NPC1 is a potential therapeutic target.</description>
    <category>Ebola</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Understanding the dynamics of Ebola epidemics</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1017-s0950268806007217-bbe032f1/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1017-s0950268806007217-bbe032f1/</guid>
    <pubDate>Tue, 26 Sep 2006 00:00:00 GMT</pubDate>
    <description>The findings suggest that rapid hospitalization is a key intervention for reducing Ebola epidemic size, providing quantitative support for containment strategies.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>COVID-19</category>
    <category>Transmission dynamics</category>
    <category>Treatment</category>
    <category>Outbreak investigation</category>
    <category>Mathematical modelling</category>
  </item>
  <item>
    <title>Ebola haemorrhagic fever in Zaire, 1976.</title>
    <link>https://globalinfectiousdisease.com/research/articles/ebola-haemorrhagic-fever-in-zaire-1976-0ab60c75/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/ebola-haemorrhagic-fever-in-zaire-1976-0ab60c75/</guid>
    <pubDate>Sun, 01 Jan 1978 00:00:00 GMT</pubDate>
    <description>A foundational outbreak investigation for Ebola surveillance and response history.</description>
    <category>Ebola</category>
    <category>Viral hemorrhagic fevers</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
  </item>
</channel>
</rss>
